IMSH Delivers Sessions - Scroll down to "ADD to your Briefcase"
Learners’ Perceptions of Simulation as a Clinical Learning Approach on SimLEARN Courses: Retrospective Study (1090-005433)
CE Hours: 1.00 Session Type: Prerecorded Educational Courses Cost: $0.00
Learning Objective 1:
Identify learners’ simulation participation satisfaction with the learning content, activities, and the learning environment to support knowledge, technical and non- technical skills development
Learning Objective 2:
Identify learners’ simulation use immediately following their introductory to simulation learning
Learning Objective 3:
Assess the impact of pre-course assessment, if conducted, for those SimLEARN courses that provide the assessment.
Content Category: Researcher
Course Overview:
Research elements, VA Research Guidelines
Co-Presenter: Dr. Nancy Wong, PhD, National SimLEARN Center About the co-presenter: Nancy Wong, SimLEARN Researcher, joined SimLEARN National Center, on March 2019. She came to EES National SimLEARN Center from Orlando VA Medical Center, OVAMC, where she was the Program Analyst for the Director’s Office. Dr. Wong earned her doctoral degree in Public Health and International Relations while she was serving in the United States Air Force. Dr. Wong conducted many clinical/non-clinical research projects through collaborative efforts with multiple international stakeholders to include the WHO, CDC, Thailand Ministry of Health, Panama Ministry of Health, PAHO, Jakarta Universiti Umum, Indonesia Ministry of Health, etc. Her research experience and emphasis were on population based clinical research primarily in the tropical regions.
Dr. Wong plans on enriching and expanding SimLEARN Research by educating, building and re-positioning research elements among SimLEARN stakeholders and provide the platforms for future research in simulation education. The ultimate goal is to enhance, improve and modernize the health care delivery and simulation education training to VA healthcare workers providing care to our Veterans.
Disclosure: No financial relationships with ineligible companies.